Timosaponin B-II alleviates osteoarthritis-related inflammation and extracellular matrix degradation through inhibition of mitogen-activated protein kinases and nuclear factor-κB pathways in vitro

Xinwei Liua Department of Orthopaedics, General Hospital of Northern Theater Command, ShenyangPeople’s Republic of ChinaView further author information

Dulei Xianga Department of Orthopaedics, General Hospital of Northern Theater Command, ShenyangPeople’s Republic of China;b Graduate School, Jinzhou Medical University, Jinzhou, People’s Republic of ChinaView further author information

Wenming Jina Department of Orthopaedics, General Hospital of Northern Theater Command, ShenyangPeople’s Republic of China;c Graduate School, China Medical University, Shenyang, People’s Republic of ChinaView further author information

Gen Zhaoa Department of Orthopaedics, General Hospital of Northern Theater Command, ShenyangPeople’s Republic of China;d Graduate School, Dalian Medical University, Dalian, People’s Republic of ChinaView further author information

Han Lia Department of Orthopaedics, General Hospital of Northern Theater Command, ShenyangPeople’s Republic of China;b Graduate School, Jinzhou Medical University, Jinzhou, People’s Republic of ChinaView further author information

Bing Xiea Department of Orthopaedics, General Hospital of Northern Theater Command, ShenyangPeople’s Republic of ChinaCorrespondence[email protected]
View further author information

Xiaochuan Gue Department of Orthopedics, Changhai Hospital, Navy Medical University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information

show all

Timosaponin B-II alleviates osteoarthritis-related inflammation and extracellular matrix degradation through inhibition of mitogen-activated protein kinases and nuclear factor-κB pathways in vitro

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Timosaponin B-II alleviates osteoarthritis-related inflammation and extracellular matrix degradation through inhibition of mitogen-activated protein kinases and nuclear factor-κB pathways in vitro

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date